Koyfin Home > Directory > Health Care > Nymox Pharm Corp

Nymox Pharm Corp Price Chart NYMX

Historical daily share price chart and data for Nymox Pharm Corp since 1997 adjusted for splits and dividends. The latest closing price for Nymox Pharm Corp as of October 23, 2020 is $2.29.
  • In 2020 the stock opened at $2.17 and closed at $2.29 for a gain of 5% YTD.
  • In 2019 the stock opened at $1.32 and closed at $2.20 for a gain of 40%.
  • In 2018 the stock opened at $3.35 and closed at $1.31 for a loss of -156%.
  • In 2017 the stock opened at $2.75 and closed at $3.30 for a gain of 17%.
View Chart On Koyfin

Nymox Pharm Corp Summary

Stock Symbol: NYMX

Nymox Pharm Corp Company Info

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) that has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia; and is in Phase II clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert test strips that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer’s disease. The company operates in Canada, the United States, Europe, and internationally. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
371.25 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of NYMX Prices